We identified ASPN, CD163, IL10, and LUM as the hub genes in the DCM development, and CD163 was verified to have the capability to diagnose DCM with the most excellent specificity and sensitivity. This evidence concerns the gene ASPN and familial dilated cardiomyopathy.